EQL Pharma
79,8
SEK
+1,01 %
EQL
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Vær den første som følger denne virksomhed
+1,01%
+26,67%
+45,62%
+58,96%
+138,92%
+136,09%
+126,06%
+523,44%
+1.384,72%
EQL Pharma is a pharmaceutical company. Currently, the focus is on development of niche and specialised pharmaceuticals, including everything from pharma for the treatment of diabetes, enlargement of blood vessels, as well as various infections and allergies. Primarily business is found in the Nordic market. EQL Pharma was founded in 2006 and is based in Lund.
Læs mereMarkedsværdi
2,32 mia. SEK
Aktieomsætning
837,19 t SEK
Omsætning
264,17 mio.
EBIT %
12,35 %
P/E
102,31
Udbytteafkast, %
-
Finanskalender
5.2
2025
Delårsrapport Q3'25
8.5
2025
Årsrapport '25
21.8
2025
Generalforsamling '25
ViserAlle indholdstyper
Correction: EQL Pharma AB (publ) signs an asset purchase agreement in respect of the acquisition of a portfolio with original pharmaceuticals
EQL Pharma AB (publ) signs an asset purchase agreement in respect of the acquisition of a portfolio with original pharmaceuticals
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools